Group 1 - Minot Light Capital Partners reported a net return of 7.6% for Q3 2025, which underperformed against benchmarks, particularly the micro-cap benchmark's return of 17.1% [1] - The fund's top five holdings were highlighted as key investment picks for 2025 [1] Group 2 - ClearPoint Neuro, Inc. (NASDAQ:CLPT) is a medical device company focused on minimally invasive surgical procedures, with a one-month return of -1.58% and a 52-week loss of 8.50% [2] - As of December 23, 2025, ClearPoint Neuro's stock closed at $14.37 per share, with a market capitalization of $427.483 million [2] - ClearPoint Neuro provides hardware and consumables for drug delivery to the brain and spine, focusing on cell and gene therapies, which creates long-term growth opportunities characterized by high switching costs and recurring revenue streams [3] - The company is emblematic of current healthcare holdings that have strong business models and high growth potential but have fallen out of favor during the healthcare sector downturn [3]